Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques

Gut

Volumn 52, Issue 1, 2003, Pages 18-23

  Egger, K ^b   Werner, M ^b   Meining, A ^b   Ott, R ^b   Allescher, H D ^b   Hofler H ^b   Classen, M ^b   Rösch, Thomas ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; VIDEORECORDING;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; BIOPSY; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIDEO RECORDING;

EID: 0037216610     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.1.18     Document Type: Article

References (39)

1. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
2. Drewitz DJ, Sampliner RE, Garewal HS. Long term follow-up of Barrett's cohort. Am J Gastroenterol 1997;92:212-15.
3. Dent J, Bremner CD, Collen MJ, et al. Working party report to the World Congress of Gastroenterology, Sydney, 1990: Barrett's esophagus. J Gastroenterol Hepatol 1991;6:1-22.
4. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
5. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophogus: An overrated risk? Gastroenterology 1984;87:927-33.
6. Spechler SJ. Endoscopic surveillance of patients with Barrett's esophagus: Does the cancer risk justify the practice? Ann Intern Med 1987;106:902-4.
7. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:613-34.
8. Canto MI, Setrakian S, Willis J, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000;51:560-8.
9. Canto MI, Setrakian S, Petras RE, et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44:1-7.
10. Gangarosa LM, Halter S, Mertz H. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low grade dysplasia. Dig Dis Sci 2000;45:225-9.
11. Canto MI. Vital staining and Barrett's esophagus. Gastrointest Endosc 1999;4:12-16.
12. Ray MB, Mayfield-Stokes S, Cecil B, et al. Results of methylene blue-directed biopsy are similar to conventional biopsy for the diagnosis of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 1997;47:AB28.
13. Gossner L, Pech O, May A, et al. Methylene blue staining for the detection of dysplasia or mucosal cancer in Barrett's esophagus: A prospective trial. Gastroenterology 1999;110:A414.
14. Gossner L, May A, Pech O, et al. Chromoendoskopie mit Methylenblau bei Barrettösophagus mit schweren Dysplasien oder Frühkarzinom. Z Gastroenterol 2000;38:663.
15. Du Vall GA, Saidi R, Kost J, et al. Real-time light-induced fluorescence endoscopy (LIFE) in the gastrointestinal (GI) tract. Gastrointest Endosc 1997;45:AB28.
16. Haringsma J, Leewen M, Tytgat GNJ. Endoscopic localization of dysplasia in laser-induced fluorescence. Gastroenterology 1997;112:A576.
17. Haringsma J, Prawirordirdjo W, Tytgat GNJ. Accuracy of fluorescence imaging of dysplasia in Barrett's esophagus. Gastroenterology 1999;116:A418.
18. Stepp H, Sroka R, Baumgartner R. Fluorescence endoscopy of gastrointestinal diseases: Basic principles, techniques, and clinical experience. Endoscopy 1998;30:379-86.
19. Marcon NE, Wilson BC. The value of fluorescence techniques in gastrointestinal endoscopy - better than the endoscopist's eye? Part 2: the North American experience. Endoscopy 1998;30:419-21.
20. Haringsma J, Tytgat GN. The value of fluorescence techniques in gastrointestinal endoscopy - Better than the endoscopist's eye? Part 1: The European experience. Endoscopy 1998;30:416-18.
21. Falk G, Rice T, Goldblum J, et al. Jumbo biopsy protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastroenterology 1999;49:170-6.
22. Werner M, Flejou JF, Haunaut P, et al. Adenocarcinoma of the esophagus. In: Aaltonen LA, Hamilton S, Kleihues P, et al, eds. WHO Classification of Tumors: Pathology and Genetics of Tumors of the Digestive System. Berlin: Springer, 2000:16-22.
23. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;223:585-9.
24. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. Ann Surg 1996;224:66-71.
25. Peters JH, Clark GW, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
26. Sharma P, Weston AP, Morales T, et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000;46:9-13.
27. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in esophagus: A follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-88.
28. Weston AP, Sharma P, Topalovski M, et al. Low-grade dysplasia in Barrett's esophagus: Variable fate during long-term follow-up. Gastroenterology 1999;116:AB G1540.
29. Messmann H. Fluoreszenzendoskopie in der gastroenterologie. Z Gastroenterol 2000;38:21-30.
30. Messmann H, Knuchel R, Endlicher E, et al. Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid: A pilot study (in German). Dtsch Med Wochenschr 1998;123:515-21.
31. Messmann H, Knuchel R, Baumler W, et al. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc 1999;49:97-101.
32. von Holstein CS, Nilson AM, Andersson-Engels S, et al. Detection of adenocarcinoma in Barrett's esophagus by means of laser-induced fluorescence. Gut 1996;39:711-16.
33. Panjehpour M, Overholt BF, Vo-Dinh T, et al. Endoscopic fluorescence detection of high grade-dysplasia in Barrett's esophagus. Gastroenterology 1996;111:93-101.
34. Wallace MB, Perelman LT, Backman V, et al. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology 2000;119:677-82.
35. Svanberg K, Klintberg C, Nilsson A, et al. Laser-based spectroscopic methods in tissue characterization. Ann N Y Acad Sci 1998;838:123-9.
36. Brand S, Bonero JM, Bouma BE, et al. Optical coherence tomography in the gastrointestinal tract. Endoscopy 2000;32:796-803.
37. Jäckle S, Gladkova N, Feldchtein F, et al. In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus. Endoscopy 2000;32:750-5.
38. Reid BJ, Blount PL, Feng Z, et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000;95:3089-96.
39. Andersson-Engels S, af Klinteberg C, Svanberg K, et al. In vivo fluorescence imaging for tissue diagnosis. Phys Med Biol 1997;42:815-24.